Clinical Trials Directory

Trials / Completed

CompletedNCT02322385

Clinical Implications of DNA Analysis on ADPKD

Mutational Types and Phenotypes Relationship in Autosomal Dominant Polycystic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Kyorin University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disease. We plan DNA analysis using the next generation sequencer (NGS) and examine the relationship between mutational types and clinical phenotypes. The accuracy of DNA analysis with NGS is tested by Sanger's method. The kidney and life survival curves will be compared between PKD1, PKD2 and non-ADPKD family members.

Detailed description

80 unrelated patients with ADPKD attending to the Kyorin University Hospital whose clinical data are compiled. DNA analysis is performed at Otsuka Pharmaceutical Laboratory. Clinical data include total kidney volume (TKV), TKV slope, eGFR, eGFR slope and other clinically relevant data.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2014-12-23
Last updated
2017-03-03

Locations

2 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT02322385. Inclusion in this directory is not an endorsement.